| Literature DB >> 18614862 |
Vincent Soriano1, Massimo Puoti, Marion Peters, Yves Benhamou, Mark Sulkowski, Fabien Zoulim, Stefan Mauss, Juergen Rockstroh.
Abstract
Nearly 10% of the estimated 36 million people having HIV worldwide suffer from chronic hepatitis B virus (HBV) infection. The advent of new antiviral agents against HBV and the recent availability of improved molecular diagnostic tools have revolutioned the management of HIV/HBV coinfected patients. The present study represents an update of the current knowledge about HBV/HIV coinfection and an intent to provide practical advise about how to give the best care to HIV-infected persons with chronic hepatitis B.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18614862 DOI: 10.1097/QAD.0b013e3282f8b46f
Source DB: PubMed Journal: AIDS ISSN: 0269-9370 Impact factor: 4.177